Estimating quality adjusted life years in the absence of standard utility values - a dynamic joint modeling approach

被引:0
作者
Deo, Vishal [1 ]
Grover, Gurprit [2 ]
机构
[1] Univ Delhi, Ramjas Coll, Dept Stat, Delhi 110007, India
[2] Univ Delhi, Fac Math Sci, Dept Stat, Delhi, India
关键词
Cost-effectiveness analysis; Health economics; HIV; AIDS; QALY; Utility function; Weibull AFT survival model; COST-EFFECTIVENESS; INDIAN ADULTS; SURVIVAL; HEALTH; CD4; TIME; MULTIATTRIBUTE; PROBABILITIES; COUNTS; CARE;
D O I
10.1080/03610918.2023.2235887
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
Estimation of Quality Adjusted Life Years (QALYs) is pivotal toward cost-effectiveness analysis (CEA) of medical interventions. The popular multi-state decision analytic modeling approach to CEA uses standard utility values assigned to each disease state to estimate QALY. In this paper, we have formulated a new approach to estimate QALY by defining utility as a function of a longitudinal covariate significantly associated with disease progression. Association parameter between the longitudinal covariate and survival times has been estimated through joint modeling of the longitudinal and the Weibull accelerated failure time survival model. MCMC techniques have been used to predict expected survival times of each censored case using the fitted model. Time-dependent utility values, calculated using projected values of the longitudinal covariate, have been used to evaluate QALYs for each patient. Proposed methodology has been demonstrated on a retrospective survival data of HIV/AIDS patients. A simulation exercise has also been carried out to gauge the predictive capability of the joint model in projecting the values of the longitudinal covariate. Results show that the proposed dynamic approach to estimate QALY can be a promising alternative to the popular multi-state decision analytic modeling approach, especially when the standard utility values are not available.
引用
收藏
页码:6540 / 6553
页数:14
相关论文
共 29 条
  • [1] Cost-Effectiveness of Tenofovir as First-Line Antiretroviral Therapy in India
    Bender, Melissa A.
    Kumarasamy, Nagalingeswaran
    Mayer, Kenneth H.
    Wang, Bingxia
    Walensky, Rochelle P.
    Flanigan, Timothy
    Schackman, Bruce R.
    Scott, Callie A.
    Lu, Zhigang
    Freedberg, Kenneth A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (03) : 416 - 425
  • [2] The estimation of a preference-based measure of health from the SF-36
    Brazier, J
    Roberts, J
    Deverill, M
    [J]. JOURNAL OF HEALTH ECONOMICS, 2002, 21 (02) : 271 - 292
  • [3] An introduction to Markov modelling for economic evaluation
    Briggs, A
    Sculpher, M
    [J]. PHARMACOECONOMICS, 1998, 13 (04) : 397 - 409
  • [4] Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation
    Coon, J. Thompson
    Hoyle, M.
    Green, C.
    Liu, Z.
    Welch, K.
    Moxham, T.
    Stein, K.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 (02) : 1 - +
  • [5] Simulating complex survival data
    Crowther, Michael J.
    Lambert, Paul C.
    [J]. STATA JOURNAL, 2012, 12 (04) : 674 - 687
  • [6] Deo Vishal, 2020, Journal of Communicable Diseases, V51, P1, DOI 10.24321/0019.5138.201919
  • [7] Survival Modeling for the Estimation of Transition Probabilities in Model-Based Economic Evaluations in the Absence of Individual Patient Data: A Tutorial
    Diaby, Vakaramoko
    Adunlin, Georges
    Montero, Alberto J.
    [J]. PHARMACOECONOMICS, 2014, 32 (02) : 101 - 108
  • [8] Comparison of the flexible parametric survival model and Cox model in estimating Markov transition probabilities using real-world data
    Du, Xudong
    Li, Mier
    Zhu, Ping
    Wang, Ju
    Hou, Lisha
    Li, Jijie
    Meng, Hongdao
    Zhou, Muke
    Zhu, Cairong
    [J]. PLOS ONE, 2018, 13 (08):
  • [9] Multiattribute and single-attribute utility functions for the health utilities index mark 3 system
    Feeny, D
    Furlong, W
    Torrance, GW
    Goldsmith, CH
    Zhu, ZL
    DePauw, S
    Denton, M
    Boyle, M
    [J]. MEDICAL CARE, 2002, 40 (02) : 113 - 128
  • [10] Extrapolating Survival from Randomized Trials Using External Data: A Review of Methods
    Jackson, Christopher
    Stevens, John
    Ren, Shijie
    Latimer, Nick
    Bojke, Laura
    Manca, Andrea
    Sharples, Linda
    [J]. MEDICAL DECISION MAKING, 2017, 37 (04) : 377 - 390